Companies / Kazia Therapeutics Ltd

Kazia Therapeutics Ltd

Nasdaq: KZIACIK 1075880SYDNEY NSW

Financials · FY2025 · AUD

RevenueA$42.0K

Net incomeA$-20.70M

Total debt—

CashA$69.46M

Diluted EPSA$-0.04

Shares outstanding809.4M

809.4M shares outstanding

Ownership

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider	% of shares	Shares
Apple Robert FDirector	—	—
Bonacorda JeffreyVP, Finance and Controller	—	—
Cain DavidDirector, CMC	—	—
Coffey Steven R. S.Director	—	—
Davidson EbruDirector	—	—
Friend John E. IICEOChief Executive Officer	—	—
Levine James E.Chief Financial Officer	—	—
Rao SudhaChief Scientific Officer	—	—
Simpson JeremyProgram Director	—	—

Holder	Value	% of shares
Alyeska Investment Group, L.P.	$5.09M	0.09%
Stonepine Capital Management, LLC	$3.17M	0.06%
Bleichroeder LP	$2.76M	0.05%
Velan Capital Investment Management LP	$2.07M	0.04%
Balyasny Asset Management L.P.	$1.44M	0.02%
Point72 Asset Management, L.P.	$1.38M	0.02%
Empery Asset Management, LP	$1.17M	0.02%
Flputnam Investment Management Co	$1.06M	0.02%
Corsair Capital Management, L.P.	$470.2K	<0.01%
Royal Bank of Canada	$255.0K	<0.01%

What insiders are doing in this stock (Form 4).

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Jun 19, 2026	Levine James E. Executive	Grant	Employee Stock Option (right to buy)	—	+200K	200,000 0.02% of shares	low
Jun 19, 2026	Rao Sudha Executive	Grant	Employee Stock Option (right to buy)	—	+250K	250,000 0.03% of shares	low

Schedule 13D / 13G

Filer	Stance	% of class	Shares	Date
Dauntless Investment Group, LLC	Passive13G/A	—	1	—
Chernett Jorey	Passive13G/A	—	—	—
Alumni Capital LP	Passive13G/A	—	—	—
Chernett Jorey	Passive13G/A	—	—	—
Lynwood Capital Management Inc.	Passive13G	—	—	—
Ikarian Capital, LLC	Passive13G	—	—	—
Chernett Jorey	Passive13G/A	—	—	—

via CUSIP / OpenFIGI

Symbol	Type	Market	CUSIP	FIGI
KZIA	ADR	Equity	48669G303	BBG000KC7878
KZIA	—	—	48669G105	—